RGEN : Analysis & Opinions

  1. Positive Results on MDCO's Cangrelor - Analyst Blog

    January 10, 2013
    The Medicines Company (MDCO) recently received good news with the company announcing positive results on its phase III candidate, ...
  2. Optimer's Dificid Sales Look Good - Analyst Blog

    January 9, 2013
    Optimer Pharmaceuticals Inc. (OPTR) recently announced its preliminary sales for the fourth quarter and full year 2012. ...
  3. Abbott's ABSORB in Phase III Trial - Analyst Blog

    January 9, 2013
    Abbott Laboratories (ABT) recently announced that its Absorb Bioresorbable Vascular Scaffold (BVS) device has moved into ...
  4. Repligen, Pfizer Collaborate - Analyst Blog

    January 8, 2013
    Repligen Corporation (RGEN) recently joined forces with Pfizer, Inc. (PFE) for the advancement of its spinal muscular atrophy ...
  5. BioMimetic's Pipeline Progresses - Analyst Blog

    January 7, 2013
    Biotechnology company, BioMimetic Therapeutics, Inc. (BMTI) recently announced that it has started enrolling patients for ...
Investing News
  1. Outside the Box: Hoisington Investment Management Quarterly Review and Outlook, First ...

    Outside the Box: Hoisington Investment Management Quarterly Review and Outlook, First Quarter ...
  2. Why Stick With Energy Stocks? (Hint: Geopolitical Risk)

    By most fundamental measures, oil prices should be declining. Russ explains why they’re on ...
  3. Bad Investor Behavior: Overemphasizing Experience

    Behavioral finance researchers have discovered that our personal experiences disproportionately ...
  4. Thoughts From The Frontline: Every Central Bank For Itself

    Thoughts from the Frontline: Every Central Bank for Itself
  5. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  6. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
Trading Center